Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.

Literature DB >> 4655684

Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.

C F George, T Fenyvesi, M E Conolly, C T Dollery.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Propranolol

Year: 1972 PMID： 4655684 DOI： 10.1007/bf00562500

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

5 in total

1. The metabolism of gluethimide (Doriden).

Authors: H KEBERLE; K HOFFMANN; K BERNHARD
Journal: Experientia Date: 1962-03-15

2. The metabolism of R(+)- and RS-pentobarbital.

Authors: K H Palmer; M S Fowler; M E Wall; L S Rhodes; W J Waddell; B Baggett
Journal: J Pharmacol Exp Ther Date: 1969-12 Impact factor: 4.030

3. Plasma propranolol levels in adults with observations in four children.

Authors: D G Shand; E M Nuckolls; J A Oates
Journal: Clin Pharmacol Ther Date: 1970 Jan-Feb Impact factor: 6.875

4. Metabolism of optically active barbiturates. II. S (-)--pentobarbital.

Authors: K H Palmer; M S Fowler; M E Wall
Journal: J Pharmacol Exp Ther Date: 1970-10 Impact factor: 4.030

5. Stereoselective metabolism of the enantiomers of hexobarbital.

Authors: R L Furner; J S McCarthy; R E Stitzel; M W Anders
Journal: J Pharmacol Exp Ther Date: 1969-10 Impact factor: 4.030

5 in total

20 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

2. Clinical pharmacokinetics of beta-adrenoreceptors blockers.

Authors: G Johnsson; C G Regårdh
Journal: Drugs Date: 1976 Impact factor: 9.546

Review 3. Altered hepatic blood flow and drug disposition.

Authors: A S Nies; D G Shand; G R Wilkinson
Journal: Clin Pharmacokinet Date: 1976 Impact factor: 6.447

4. Contribution of the liver to overall elimination of propranolol.

Authors: C F George; M L Orme; P Buranapong; D Macerlean; A M Breckenridge; C T Dollery
Journal: J Pharmacokinet Biopharm Date: 1976-02

Review 5. The assessment of beta-adrenoceptor blocking drugs in man.

Authors: D G McDevitt
Journal: Br J Clin Pharmacol Date: 1977-08 Impact factor: 4.335

6. Pharmacokinetics of pindolol in man.

Authors: R Gugler; W Herold; H J Dengler
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

7. Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma.

Authors: A Wellstein; D Palm; G Wiemer; M Schäfer-Korting; E Mutschler
Journal: Eur J Clin Pharmacol Date: 1984 Impact factor: 2.953